These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 33524423)

  • 1. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    Tanaka A; Yamamoto S; Miyo K; Mizoue T; Maeda K; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Apr; 82(4):e1-e3. PubMed ID: 33524423
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    Yamamoto S; Tanaka A; Oshiro Y; Ishii M; Ishiwari H; Konishi M; Matsuda K; Ozeki M; Miyo K; Maeda K; Mizoue T; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34044036
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis.
    Jones CR; Hamilton FW; Thompson A; Morris TT; Moran E
    J Infect; 2021 Mar; 82(3):e24-e27. PubMed ID: 33271169
    [No Abstract]   [Full Text] [Related]  

  • 4. Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021.
    Sanada T; Honda T; Yasui F; Yamaji K; Munakata T; Yamamoto N; Kurano M; Matsumoto Y; Kohno R; Toyama S; Kishi Y; Horibe T; Kaneko Y; Kakegawa M; Fukui K; Kawamura T; Daming W; Qian C; Xia F; He F; Yamasaki S; Nishida A; Harada T; Higa M; Tokunaga Y; Takagi A; Itokawa M; Kodama T; Kohara M
    J Epidemiol; 2022 Feb; 32(2):105-111. PubMed ID: 34776499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.
    Yoshihara T; Ito K; Zaitsu M; Chung E; Aoyagi I; Kaji Y; Tsuru T; Yonemura T; Yamaguchi K; Nakayama S; Tanaka Y; Yurino N; Koyanagi H; Matsuki S; Urae R; Irie S
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to the Letter to the Editor Regarding "Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020-2021".
    Sanada T; Kohara M
    J Epidemiol; 2023 Feb; 33(2):109. PubMed ID: 35908936
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.
    Nishimura T; Uwamino Y; Uno S; Kashimura S; Shiraki T; Kurafuji T; Morita M; Noguchi M; Azegami T; Yamada-Goto N; Murai-Takeda A; Yokoyama H; Kuwabara K; Kato S; Matsumoto M; Hirata A; Iida M; Harada S; Ishizaka T; Misawa K; Murata M; Saya H; Amagai M; Kitagawa Y; Takeuchi T; Mori M; Takebayashi T; Hasegawa N;
    Intern Med; 2021 Aug; 60(16):2569-2575. PubMed ID: 34148952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal.
    Silva DF; Silva PD; Torgal A; Braga S; Rocha D; Ochoa C; Oliveira Á; Rocha L; Dias JM; Baldaque I
    Acta Med Port; 2021 Jun; 34(6):484-485. PubMed ID: 34715953
    [No Abstract]   [Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan.
    Matsunaga H; Makino A; Kato Y; Murakami T; Yamaguchi Y; Kumanogoh A; Oba Y; Fujimi S; Honda T; Tomonaga K
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
    Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan.
    Yamayoshi S; Nagai E; Mitamura K; Hagihara M; Kobayashi R; Takahashi S; Shibata A; Uwamino Y; Hasegawa N; Iqbal A; Kamimaki I; Iwatsuki-Horimoto K; Nagamura-Inoue T; Kawaoka Y
    Epidemiol Infect; 2024 Jan; 152():e24. PubMed ID: 38258464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control.
    Hibino M; Iwabuchi S; Munakata H
    J Hosp Infect; 2021 Jan; 107():103-104. PubMed ID: 33039454
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital.
    Madhusudan M; Sankar J; Dhanalakshmi K; Putlibai S; Balasubramanian S
    Indian Pediatr; 2021 Mar; 58(3):279-280. PubMed ID: 33713065
    [No Abstract]   [Full Text] [Related]  

  • 19. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.